CHS-0214 (etanercept biosimilar) - Coherus
Coherus: Q2 2015 Results (Coherus) - Aug 14, 2015 - Anticipated topline data from P3 trial (NCT02115750) for RA in Q1 2016; Anticipated topline data from P3 trial (NCT02134210) for psoriasis in Q4 2015 
Anticipated P3 data: top line • Biosimilar
http://investors.coherus.com/phoenix.zhtml?c=253655&p=irol-newsArticle&ID=2078509
 
Aug 14, 2015
 
.